Article History
Received: 17 October 2022
Accepted: 28 March 2023
First Online: 11 May 2023
Competing interests
: J.R. is a consultant and received research funding from Pfizer and is an adviser and stock owner in Colorado Research Partners, L.E.A.F. Pharmaceuticals, Rafael Pharmaceuticals, Barer Institute and its subsidiaries, Serien Therapeutics, Empress Therapeutics, and Agios Pharmaceuticals. J.R. is co-inventor of SHIN2 and related SHMT inhibitors, which have been patented by Princeton University. The remaining authors declare no competing interests.